SPX Technologies (SPXC)

NYSEIndustrialsConstruction MaterialsSnapshot 2026-10-23

$160.33+0.20%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge SPX Technologies’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-0.0%

+10% or more+5%0%−5%−10% or less

9.72 → 9.72 EPS · FY ending Dec 31, 2027 · 7 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 8 to 7; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q4
Revenue	—	803.94M
EPS	—	2.51
FY 2026 · Annual
Revenue	—	2.76B
EPS	$8.2–$8.6non-GAAP	8.347
EBITDA	$630M–$660Mnon-GAAP	—
FY 2027 · Annual
Revenue	—	3.14B
EPS	—	9.721

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Cash flow from operations improves to at least $30.6 million by Q1 FY26	Cash flow from operations turned positive, improving by $41.5M.	Intact	Cash flow from operations falls below zero in Q1 FY26	Cash from operations: $89.6M FY2026-Q2; GAAP. Published target: >= $30.6 million. Target period is not explicitly aligned with this observation. Source published Jul 31, 202689,600,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 27, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. Net operating cash flow improved from negative $10.9M in 2025-Q1 to $89.6M in 2026-Q2, showing significant recovery and strength. Management is making progress improving cash flow to support investments, though quarterly variability remains. Delivery assessment Oct 24, 2026
Operating income improves to at least $87.7 million by Q1 FY26	Profit improves with operating income rising from $66.6M to $87.7M in a year.	Intact	Operating income falls below $66.6 million in Q1 FY26	Operating income: $115M FY2026-Q2; GAAP. Published target: >= $87.7 million. Target period is not explicitly aligned with this observation. Source published Jul 30, 2026115,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 27, 2026 Source: company_financial_results. Reference: af888fe0-d626-40b7-a993-b645d44c4bea. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. Operating income increased from $66.6M in 2025-Q1 to $115.0M in 2026-Q2, a 72.7% increase. Adjusted EBITDA guidance for 2026 was raised to $630-$660M, about 27% higher year-over-year at midpoint. Management is delivering improved operating income through growth and cost initiatives. Delivery assessment Oct 24, 2026
Revenue reaches at least $2.61 billion in FY26	A primary condition in SPX Technologies's published investment case. The stated target is >= $2.61 billion.	Intact	Revenue falls below $2.25 billion in FY26	Revenue: $679M FY2026-Q2; GAAP. Published target: >= $2.61 billion. Target period is not explicitly aligned with this observation. Source published Jul 30, 2026679,000,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 27, 2026 Source: company_financial_results. Reference: af888fe0-d626-40b7-a993-b645d44c4bea. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 4 of last 4 quarters. Revenue increased from $482.6M in 2025-Q1 to $679.0M in 2026-Q2, a 40.7% increase. Full-year 2026 revenue guidance was raised to $2.705-$2.765B, about 21% higher year-over-year at midpoint. Management is delivering on revenue growth through organic expansion, acquisitions, and capacity increases. Delivery assessment Oct 24, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$9.72

$9.10 → $9.72 · observed estimates

FY2027 revenue$3.14B

$2.85B → $3.14B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$9.10	$2,846,608,830	12 / 12
2026-07-25	$9.10	$2,846,608,830	12 / 12
2026-07-26	$9.10	$2,846,608,830	12 / 12
2026-07-27	$9.10	$2,844,521,980	11 / 11
2026-07-28	$9.10	$2,844,521,980	11 / 11
2026-07-29	$9.10	$2,846,642,912	8 / 9
2026-07-30	$9.10	$2,844,521,980	11 / 11
2026-07-31	$9.10	$2,844,521,980	11 / 11
2026-08-01	$9.10	$2,846,642,912	8 / 9
2026-08-02	$9.10	$2,844,521,980	11 / 11
2026-08-03	$9.45	$2,968,075,412	7 / 7
2026-08-04	$9.45	$2,968,075,412	7 / 7
2026-08-05	$9.45	$2,968,075,412	7 / 7
2026-08-06	$9.69	$3,044,087,150	10 / 10
2026-08-08	$9.69	$3,044,087,150	10 / 10
2026-08-09	$9.45	$2,968,075,412	7 / 7
2026-08-10	$9.69	$3,044,087,150	10 / 10
2026-08-12	$9.45	$2,968,075,412	7 / 7
2026-08-13	$9.69	$3,044,087,150	10 / 10
2026-08-14	$9.45	$2,968,075,412	7 / 7
2026-08-15	$9.45	$2,968,075,412	7 / 7
2026-08-16	$9.45	$2,968,075,412	8 / 8
2026-08-17	$9.45	$2,968,075,412	8 / 8
2026-08-18	$9.45	$2,968,075,412	8 / 9
2026-08-19	$9.45	$2,968,075,412	8 / 9
2026-08-20	$9.72	$3,043,885,600	8 / 9
2026-08-21	$9.72	$3,043,885,600	8 / 9
2026-08-22	$9.72	$3,043,885,600	8 / 9
2026-08-23	$9.72	$3,043,885,600	8 / 9
2026-08-24	$9.72	$3,043,885,600	8 / 9
2026-08-25	$9.72	$3,043,885,600	8 / 9
2026-08-26	$9.72	$3,043,885,600	8 / 9
2026-08-27	$9.72	$3,043,885,600	8 / 9
2026-08-28	$9.72	$3,043,885,600	8 / 9
2026-08-29	$9.72	$3,043,885,600	8 / 9
2026-08-30	$9.72	$3,043,885,600	8 / 9
2026-08-31	$9.72	$3,043,885,600	8 / 9
2026-09-01	$9.72	$3,043,885,600	8 / 9
2026-09-02	$9.72	$3,043,885,600	8 / 9
2026-09-03	$9.72	$3,043,885,600	8 / 9
2026-09-04	$9.72	$3,043,885,600	8 / 9
2026-09-05	$9.72	$3,043,885,600	8 / 9
2026-09-06	$9.72	$3,043,885,600	8 / 9
2026-09-07	$9.72	$3,043,885,600	8 / 9
2026-09-08	$9.72	$3,043,885,600	8 / 9
2026-09-09	$9.72	$3,043,885,600	8 / 9
2026-09-10	$9.72	$3,043,885,600	8 / 9
2026-09-11	$9.72	$3,043,885,600	8 / 9
2026-09-12	$9.80	$3,066,335,600	8 / 9
2026-09-13	$9.80	$3,066,335,600	8 / 9
2026-09-14	$9.80	$3,066,335,600	8 / 9
2026-09-15	$9.80	$3,066,335,600	8 / 9
2026-09-16	$9.74	$3,057,668,934	8 / 9
2026-09-17	$9.74	$3,057,668,934	9 / 9
2026-09-18	$9.74	$3,057,668,934	9 / 9
2026-09-19	$9.74	$3,057,668,934	9 / 9
2026-09-20	$9.75	$3,066,585,600	8 / 9
2026-09-21	$9.75	$3,066,585,600	8 / 9
2026-09-22	$9.75	$3,066,585,600	8 / 9
2026-09-23	$9.72	$3,077,975,790	8 / 9
2026-09-24	$9.72	$3,077,975,790	8 / 9
2026-09-25	$9.72	$3,077,975,790	8 / 9
2026-09-26	$9.72	$3,077,975,790	8 / 9
2026-09-27	$9.72	$3,077,975,790	8 / 9
2026-09-28	$9.72	$3,077,975,790	8 / 9
2026-09-29	$9.72	$3,077,975,790	8 / 9
2026-09-30	$9.72	$3,077,975,790	8 / 9
2026-10-01	$9.72	$3,088,399,737	8 / 9
2026-10-02	$9.72	$3,088,399,737	9 / 9
2026-10-03	$9.72	$3,099,007,429	9 / 9
2026-10-04	$9.72	$3,099,007,429	9 / 9
2026-10-05	$9.72	$3,099,007,429	9 / 9
2026-10-06	$9.72	$3,109,628,327	9 / 9
2026-10-07	$9.71	$3,117,556,898	9 / 11
2026-10-08	$9.71	$3,117,556,898	6 / 6
2026-10-09	$9.72	$3,124,808,829	6 / 7
2026-10-10	$9.72	$3,124,808,829	6 / 7
2026-10-11	$9.72	$3,131,951,686	7 / 7
2026-10-12	$9.72	$3,131,951,686	7 / 7
2026-10-13	$9.72	$3,131,951,686	7 / 7
2026-10-14	$9.72	$3,139,842,336	7 / 7
2026-10-15	$9.72	$3,139,842,336	7 / 7
2026-10-16	$9.72	$3,139,842,336	7 / 7
2026-10-17	$9.72	$3,139,842,336	7 / 7
2026-10-18	$9.72	$3,139,842,336	7 / 7
2026-10-19	$9.72	$3,139,842,336	7 / 7
2026-10-20	$9.72	$3,139,842,336	7 / 7
2026-10-21	$9.72	$3,139,842,336	7 / 7
2026-10-22	$9.72	$3,139,849,479	7 / 7
2026-10-23	$9.72	$3,139,849,479	7 / 7
2026-10-24	$9.72	$3,139,849,479	7 / 7

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	11	1
2026-06-01	11	1
2026-07-01	11	1
2026-08-01	11	1
2026-09-01	12	1
2026-10-01	13	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 13 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades5 maintains

Recent actions · Sep 25–Oct 24 · 5 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Wells FargoOct 13 · prior Aug 3

$250.00 → $243.00-2.8%

Truist FinancialOct 5 · prior Jul 2

$295.00 → $266.00-9.8%

Robert W. BairdOct 5

$220.00New observation · no comparable prior

OppenheimerOct 2 · prior Jul 20

$280.00 → $270.00-3.6%

Vertical ResearchSep 28

$215.00New observation · no comparable prior

$0$162.25$324.50

0 raises · 3 cuts · 0 unchanged · 2 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Cash flow from operations improves to at least $30.6 million by Q1 FY26Cash from operations: $89.6M
Operating income improves to at least $87.7 million by Q1 FY26Operating income: $115M
Revenue reaches at least $2.61 billion in FY26Revenue: $679M

Next proof point

Oct 29, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.5%Typical daily move · historical

Downside history

-35.1%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

SPX Technologies outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

SPXC is a growth-oriented industrial business, with recent gains supported by organic expansion, acquisitions, and added capacity. Its long-term thesis is intact, but the signal has eased from favorable to mildly favorable and cash flow progress is mixed.

What's priced into SPX Technologies

The valuation evidence is mixed: one measure describes SPXC as cheap versus peers, while another shows a sizable premium to peers. The model labels expectations as justified, with low fragility, so the evidence does not point to unusually stretched expectations overall.

What the fundamentals likely do

Near term, recent results and raised 2026 guidance support continued revenue and operating income growth, and management is on track on both priorities. Cash flow has improved but remains variable; elevated risk, a sector headwind, and a history of a deep miss leave execution as a concern.

What SPX Technologies hinges on

A key swing factor is whether SPXC sustains delivery after raising guidance; a reversal and guidance cut could damage management credibility. Over the multi-year view, results also depend on sector conditions: continued strong results from JCI, MAS, and CSL would support the industrial backdrop, while misses or lower guidance could weaken it.